On top of your game Reg,
As Silviu pointed out to me at the last AGM, Mesoblast are having ongoing discussions with the FDA - it is a bureaucracy but with VERY Pragmatic NEW leadership.
Rexlemestrocel-L is in development for advancedchronic heart failure and chronic low back pain. Two products have beencommercialized in Japan and Europe by Mesoblast’s licensees, and the Companyhas established commercial partnerships in Europe and China for certain Phase 3assets, this tells me that it's only a matter of time for MSB to achieve the FDA outcomes we all believe in.
@ddwn closing posts : "Onwards & Upwards"
ST
- Forums
- ASX - By Stock
- Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
On top of your game Reg,As Silviu pointed out to me at the last...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
91.5¢ |
Change
-0.010(1.08%) |
Mkt cap ! $1.050B |
Open | High | Low | Value | Volume |
92.0¢ | 92.5¢ | 91.5¢ | $449.8K | 489.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 224760 | 91.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 54871 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 224760 | 0.915 |
24 | 220412 | 0.910 |
9 | 49761 | 0.905 |
43 | 365236 | 0.900 |
9 | 388314 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 54867 | 31 |
0.925 | 103327 | 18 |
0.930 | 89659 | 10 |
0.935 | 121086 | 5 |
0.940 | 16560 | 4 |
Last trade - 11.47am 18/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |